Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Cyst Fibros ; 18(2): 203-211, 2019 03.
Article in English | MEDLINE | ID: mdl-29960875

ABSTRACT

Cystic fibrosis (CF) lung disease is characterized by aggressive neutrophil-dominated inflammation mediated in large part by neutrophil elastase (NE), an omnivorous protease released by activated or disintegrating neutrophils and a key therapeutic target. To date, several short-term studies have shown that anti-NE compounds can inhibit NE and have anti-inflammatory effects. However, progression to large-scale or multicenter clinical trials has been hampered by the fact that the current gold standard methodology of evaluating airway NE inhibition, bronchoalveolar lavage (BAL), is invasive, difficult to standardize across sites and excludes those with severe lung disease. Attempts to utilize sputum that is either spontaneously expectorated (SS) or induced (IS) have been hindered by poor reproducibility, often due to the various processing methods employed. In this study, we evaluate TEmperature-controlled Two-step Rapid Isolation of Sputum (TETRIS), a specialized method for the acquisition and processing of SS and IS. Using TETRIS, we show for the first time that NE activity and cytokine levels are comparable in BAL, SS and IS samples taken from the same people with CF (PWCF) on the same day once this protocol is used. We correlate biomarkers in TETRIS-processed IS and clinical outcome measures including FEV1, and show stability and reproducible inhibition of NE over time in IS processed by TETRIS. The data offer a tremendous opportunity to evaluate prognosis and therapeutic interventions in CF and to study the full spectrum of people with PWCF, many of whom have been excluded from previous studies due to being unfit for BAL or unable to expectorate sputum.


Subject(s)
Cystic Fibrosis , Inflammation , Leukocyte Elastase , Lung , Specimen Handling/methods , Sputum/immunology , Adult , Cystic Fibrosis/immunology , Cystic Fibrosis/therapy , Female , Humans , Inflammation/diagnosis , Inflammation/immunology , Interleukin-1beta/immunology , Leukocyte Elastase/analysis , Leukocyte Elastase/immunology , Lung/immunology , Lung/physiopathology , Male , Neutrophil Activation/immunology , Procedures and Techniques Utilization , Prognosis , Proteinase Inhibitory Proteins, Secretory/pharmacology , Reproducibility of Results , Respiratory Function Tests/methods
2.
Ir J Med Sci ; 187(2): 429-434, 2018 May.
Article in English | MEDLINE | ID: mdl-28812224

ABSTRACT

BACKGROUND: Candidaemia is an important nosocomial infection, seen frequently in immunocompromised and critically ill patients and increasingly recognised in cystic fibrosis (CF) patients with totally implantable venous access devices (TIVADs). This study aims to investigate the incidence and risk factors for the development of TIVAD-associated candidaemia and to assess the rate of TIVAD-related complications in CF patients. METHODS: A 10-year retrospective study was carried out on adult CF patients attending a single centre. Complications were recorded including the incidence of candidaemia and correlated to clinical parameters. Complication rates were calculated based on incidence per 1000 catheter days. Statistical analysis was performed using Mann-Whitney U test and Fisher's exact test. RESULTS: Fourteen cases of candidaemia were observed in the CF cohort, primarily caused by Candida parapsilosis and Candida albicans. Candidaemia was associated with lower FEV1 (p = 0.0117) and higher frequency of pulmonary exacerbation (p < 0.0001). A TIVAD complication rate of 0.337/1000 catheter days was observed in the CF cohort. Complications included venous thrombosis, stenosis, and port extrusion; complications were independently associated with more frequent pulmonary exacerbations (p = 0.04). CONCLUSIONS: TIVAD complications are observed more commonly in those with lower FEV1 and frequent pulmonary exacerbations, suggesting that candidaemia may be related to antibiotic use and furthermore can occur following invasive procedures causing translocation of fungal species allowing transformation from colonisation to pathogenic infection.


Subject(s)
Candida/pathogenicity , Cystic Fibrosis/complications , Prostheses and Implants/adverse effects , Adult , Cystic Fibrosis/therapy , Female , Humans , Incidence , Male , Retrospective Studies , Risk Factors
4.
Ir Med J ; 110(10): 656, 2017 Dec 18.
Article in English | MEDLINE | ID: mdl-29465846

ABSTRACT

Isolated unilateral pulmonary artery agenesis is a rare diagnosis. Poor blood flow to the lung parenchyma renders the tissue susceptible to opportunistic infections. We present the unusual case of isolated unilateral pulmonary artery agenesis complicated by aspergilloma. Management options and considerations are discussed.


Subject(s)
Pulmonary Artery/abnormalities , Pulmonary Aspergillosis/complications , Humans , Lung/blood supply
6.
Ir J Med Sci ; 180(2): 607-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-19662491

ABSTRACT

INTRODUCTION: Cystic fibrosis (CF) is of particular importance in Ireland as the Irish population has both the highest incidence (2.98/10,000) and the highest carrier rate (1 in 19) in the world. Primary immunodeficiency has not been previously reported as co-existing with CF. CASE REPORT: We report a unique case of CF associated with a primary immunodeficiency syndrome--common variable immunodeficiency (CVID). DISCUSSION: Our patient has CF, CVID and the additional comorbidity of Aspergers syndrome. The challenges inherent in diagnosing and treating such a case are outlined herein and the successful management of this case is evidenced by the well-preserved lung function of our patient.


Subject(s)
Asperger Syndrome/complications , Common Variable Immunodeficiency/complications , Cystic Fibrosis/complications , Adult , Asperger Syndrome/psychology , Common Variable Immunodeficiency/diagnosis , Cystic Fibrosis/drug therapy , Humans , Male , Patient Compliance/psychology , Young Adult
8.
Ir Med J ; 102(7): 204-6, 2009.
Article in English | MEDLINE | ID: mdl-19771998

ABSTRACT

Infertility rates among males with cystic fibrosis (CF) approximate 97%. No information is currently available within Ireland determining an understanding of fertility issues and the best methods of information provision to this specialized group. This study aimed to determine understanding and preferred approaches to information provision on fertility issues to Irish CF males. A Descriptive Study utilizing prospective coded questionnaires was mailed to a male CF cohort (n=50). Sections included demographics, fertility knowledge & investigation. Response rate was 16/50 (32%). All were aware that CF affected their fertility. More than two-thirds (n=11) were able to provide explanations whilst only one-third (n=5) provided the correct explanation. Significant numbers stated thoughts of marriage and a future family. Half have discussed fertility with a healthcare professional (HCP). Mean age of discussion was 21.9 years. One third preferred an earlier discussion. The commonest first source for information was written material which was also the preferred source. Three-quarters requested further information preferring again, written material. Significant gaps in sex education of Irish CF males exist. Discussion should be initiated by HCPs and centre-directed written material devised to address deficiencies.


Subject(s)
Cystic Fibrosis/epidemiology , Health Knowledge, Attitudes, Practice , Infertility, Male/epidemiology , Adult , Counseling , Cystic Fibrosis/etiology , Health Education/statistics & numerical data , Humans , Infertility, Male/etiology , Ireland/epidemiology , Male , Prospective Studies , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...